-
Product Insights
New![]()
KSEB TP Saurya Solar PV Park
KSEB TP Saurya Solar PV Park is a solar PV project located in Rajasthan, India. The project is owned and being developed by TP Saurya Ltd. The project is at the permitting stage. Empower your strategies with our KSEB TP Saurya Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
New![]()
GUVNL TP Saurya Solar PV Park
GUVNL TP Saurya Solar PV Park is a solar PV project located in Gujarat, India. The project is owned and being developed by TP Saurya Ltd. The project is at the permitting stage. Empower your strategies with our GUVNL TP Saurya Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
New![]()
TP Saurya Jamshedpur Solar PV Park
TP Saurya Jamshedpur Solar PV Park is a solar PV project located in Jharkhand, India. The project is owned and being developed by TP Saurya Ltd. The project is at the permitting stage. Empower your strategies with our TP Saurya Jamshedpur Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Company Insights
New![]()
Innovation and Patenting activity of TP ICAP Group plc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of TP ICAP Group plc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-04 in Rosacea
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-04 in Rosacea Drug Details:TP-04 is under development for the treatment of rosacea.Report CoverageThe data is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-05 in Malaria
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-05 in Malaria Drug Details:Lotilaner is under development for the prevention of lyme disease and community...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-3654 in Myelofibrosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-3654 in Myelofibrosis Drug Details:TP-3654 (SGI-9481) is under development for the treatment of bladder cancer, primary...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-1287 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-1287 in Solid Tumor Drug Details:TP-1287 is under development for the treatment of ewing sarcomasolid tumor,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-1454 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-1454 in Solid Tumor Drug Details:TP-1454 is under development for the treatment of solid tumors including...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TP-05 in Lyme Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-05 in Lyme Disease Drug Details:Lotilaner is under development for the prevention of lyme disease and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.